CoChat

Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression

Open access
Guo, Wei, Machado-Vieira, Rodrigo, Mathew, Sanjay, Murrough, James W., Charney, Dennis S., Grunebaum, Matthew, Oquendo, Maria A., Kadriu, Bashkim, Akula, Nirmala, Henter, Ioline, Yuan, Peixiong, Merikangas, Kathleen, Drevets, Wayne, Furey, Maura, Mann, J. John, McMahon, Francis J., Zarate, Carlos A., Shugart, Yin Yao · 2018 · Translational Psychiatry
Cited by 38

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Growing evidence suggests that the glutamatergic modulator ketamine has rapid antidepressant effects in treatment-resistant depressed subjects. The anticholinergic agent scopolamine has also shown promise as a rapid-acting antidepressant. This study applied genome-wide markers to investigate the role of genetic variants in predicting acute antidepressant response to both agents. The ketamine-treated sample included 157 unrelated European subjects with major depressive disorder (MDD) or bipolar disorder (BD). The scopolamine-treated sample comprised 37 unrelated European subjects diagnosed with either MDD or BD who had a current Major Depressive Episode (MDE), and had failed at least two adequate treatment trials for depression. Change in Montgomery–Asberg Depression Rating Scale (MADRS) or the 17-item Hamilton Depression Rating Scale (HAM-D) scale scores at day 1 (24 h post-treatment) was considered the primary outcome. Here, we conduct pilot genome-wide association study (GWAS) analyses to identify potential markers of ketamine response and dissociative side effects. Polygenic risk score analysis of SNPs ranked by the strength of their association with ketamine response was then calculated in order to assess whether common genetic markers from the ketamine study could predict response to scopolamine. Findings require replication in larger samples in light of low power of analyses of these small samples. Neverthless, these data provide a promising illustration of our future potential to identify genetic variants underlying rapid treatment response in mood disorders and may ultimately guide individual patient treatment selection in the future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-018-0311-7

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 38

Metadata

Authors
Guo, W., Machado-Vieira, R., Mathew, S., Murrough, J. W., Charney, D. S., Grunebaum, M., Oquendo, M. A., Kadriu, B., Akula, N., Henter, I., Yuan, P., Merikangas, K., Drevets, W., Furey, M., Mann, J. J., McMahon, F. J., Zarate, C. A., & Shugart, Y. Y.
Venue
Translational Psychiatry
Published
2018-12-14
Volume
8
Issue
1
Pages
108-108
ISSN
2158-3188 (ISSN-L)
OpenAlex
W2905493409
Cited by
38
References
22
FWCI
2.98
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression. https://app.cochat.ai/papers/10.1038/s41398-018-0311-7
The paper
Guo, W., Machado-Vieira, R., Mathew, S., Murrough, J. W., Charney, D. S., Grunebaum, M., Oquendo, M. A., Kadriu, B., Akula, N., Henter, I., Yuan, P., Merikangas, K., Drevets, W., Furey, M., Mann, J. J., McMahon, F. J., Zarate, C. A., & Shugart, Y. Y. (2018). Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression. Translational Psychiatry. https://doi.org/10.1038/s41398-018-0311-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.